Claude J. Stoufs
Director/Board Member at AK Diagnostics Europe BV
Profile
Claude J.
Stoufs is currently a Director at Biocleave Ltd., AK Diagnostics Europe BV, Frx Polymers NV, and a Member-Supervisory Board at Avantium Technologies BV.
He has formerly held Director positions at TiGenix NV, Urogene SA, Valerio Therapeutics SA, elbion AG, Fluxome Sciences A, Alaska Food Diagnostics Ltd., FRX Polymers, Inc., and FlandersBio vzw.
He was also a Manager-Mergers & Acquisitions at FMC Corp.
and Occidental Chemical Corp.
Mr. Stoufs was a Partner at Capricorn Partners NV from 2013 to 2018 and a Member-Supervisory Board at Avantium NV from 2008 to 2017.
He received his undergraduate and graduate degrees from Université Libre de Bruxelles.
Claude J. Stoufs active positions
Companies | Position | Start |
---|---|---|
AK Diagnostics Europe BV
AK Diagnostics Europe BV Miscellaneous Commercial ServicesCommercial Services Formed in 2008 as joint venture Company between Dutch Technology Fund I.B.V. and Alaska Food Diagnostics Ltd (UK), AK Diagnostics is further developing and marketing Alaska's AK-PhageTM Technology to provide new benefits in pathogen screening in the Primary Food Sector. Together with Alaska and RnA Assays BV, AK Diagnostics is collaborating in a EUREKA approved project for the testing of blood, meat drip and eggs of animals (principally pigs, cattle and poultry) at farm level or during slaughter. | Director/Board Member | 2009-03-23 |
Biocleave Ltd.
Biocleave Ltd. BiotechnologyHealth Technology Biocleave Ltd. develops and sells microbial technology for the production of renewable chemicals and biofuels. It also provides biobutanol and other C4 chemical products. The firm also engages in microbiology and metabolic engineering through fermentation and commercial production scale. Its products include biobutanol chemicals and fuel, acetone, and butyric acid. The company was founded by Edward M. Green in 2003 and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | - |
Avantium Technologies BV
Avantium Technologies BV Miscellaneous Commercial ServicesCommercial Services Avantium Technologies BV operates as chemical technology company. It offers a breeding ground for revolutionary renewable chemistry solutions. The firm specializes in innovations and technologies for catalytic research and development services and systems. The company was founded in February 2000 and is headquartered in Amsterdam, the Netherlands | Director/Board Member | - |
Frx Polymers NV
Frx Polymers NV Chemicals: SpecialtyProcess Industries Frx Polymers NV is a Belgian company that manufactures and supplies homopolymers, copolymers, and oligomers. The private company is based in Antwerp, Belgium. | Director/Board Member | - |
Former positions of Claude J. Stoufs
Companies | Position | End |
---|---|---|
Capricorn Partners NV
Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Private Equity Investor | 2018-09-30 |
AVANTIUM N.V. | Director/Board Member | 2017-06-13 |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | Director/Board Member | 2013-08-07 |
Alaska Food Diagnostics Ltd.
Alaska Food Diagnostics Ltd. Miscellaneous Commercial ServicesCommercial Services Alaska Food Diagnostics Ltd. provides ultrasensitive rapid detection systems to the food and beverage markets. It offers FastrAK Salmonella, an ultra rapid testing system for food manufacturers. The company was founded in August 2000 and is headquartered in Salisbury, UK. | Director/Board Member | 2011-11-06 |
Occidental Chemical Corp.
Occidental Chemical Corp. Chemicals: Major DiversifiedProcess Industries Occidental Chemical Corp. manufactures polyvinyl chloride resins, chlorine and caustic soda. It also offers basic chemicals, oxyvinyls, food grade and armand products. The company was founded in 1988 and is headquartered in Dallas, TX. | Corporate Officer/Principal | - |
Training of Claude J. Stoufs
Université Libre de Bruxelles | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
FMC CORPORATION | Process Industries |
VALERIO THERAPEUTICS | Health Technology |
AVANTIUM N.V. | Producer Manufacturing |
Private companies | 13 |
---|---|
TiGenix NV
TiGenix NV Medical SpecialtiesHealth Technology TiGenix NV engages in the research, development, and commercialization of biopharmaceutical products. The firm's portfolio includes allogeneic adipose-derived stem cells and allogeneic cardiac stem cells. It intends to treat Crohn's disease, sepsis, autoimmune disorders, acute myocardial infarction, and chronic cardiovascular indication. The company was founded by Gil Beyen and Frank P. Luyten on February 21, 2000 and is headquartered in Leuven, Belgium. | Health Technology |
Capricorn Partners NV
Capricorn Partners NV Investment ManagersFinance Capricorn Partners NV (Capricorn) is an independent European licensed manager of private and public equity investment funds which was founded in 1993 as a joint venture between Dr Jos B. Peeters and Baring Venture Partners Ltd. In 1999, Capricorn became a fully partner-owned, independent firm. It is headquartered in Leuven, Belgium. | Finance |
Urogene SA
Urogene SA Miscellaneous Commercial ServicesCommercial Services Urogene is a urology-focused biopharmaceutical company engaged in the development of small molecule drugs for the treatment of: Lower Urinary Tract Dysfunctions such as overactive bladder and stress urinary incontinence, Prostate and Bladder Cancers. They have the expertise to set-up and manage preclinical and clinical development plans in these therapeutic areas. Its objective is to provide innovative candidates with clinical proof-of-concept of efficacy and safety. Partnerships with key players in the urology field will be proposed for late-stage clinical development and commercialization. Besipirdine, in-licensed from Aventis, is now reaching that stage. It is a potential novel first-in-class oral treatment for Overactive Bladder (OAB) currently in Phase II development. Development is planned in additional indications including Interstitial Cystitis (IC) and Stress-related Urinary Incontinence (SUI). Besipirdine represents a potential breakthrough and novel blockbuster product in OAB, SUI, mixed incontinence and IC. | Commercial Services |
Occidental Chemical Corp.
Occidental Chemical Corp. Chemicals: Major DiversifiedProcess Industries Occidental Chemical Corp. manufactures polyvinyl chloride resins, chlorine and caustic soda. It also offers basic chemicals, oxyvinyls, food grade and armand products. The company was founded in 1988 and is headquartered in Dallas, TX. | Process Industries |
Avantium Technologies BV
Avantium Technologies BV Miscellaneous Commercial ServicesCommercial Services Avantium Technologies BV operates as chemical technology company. It offers a breeding ground for revolutionary renewable chemistry solutions. The firm specializes in innovations and technologies for catalytic research and development services and systems. The company was founded in February 2000 and is headquartered in Amsterdam, the Netherlands | Commercial Services |
elbion AG
elbion AG Miscellaneous Commercial ServicesCommercial Services elbion AG discovers and develops new small molecule drugs for the treatment of inflammatory and central nervous system diseases with high unmet medical need. It's lead product candidate AWD 12-281 is a topical inhibitor and is in phase IIa trials for the treatment of chronic obstructive pulmonary disease and has licensed it to GlaxoSmithKline for exclusive development and commercialization. It focuses on target areas, including PDE inhibitors and CNS modulators, in terms of novel chemistries, novel assays and mechanisms of action, as well as in-house animal disease models. Founded in 2002, the company is headquartered in Radebeul, Germany. | Commercial Services |
Fluxome Sciences A/S
Fluxome Sciences A/S BiotechnologyHealth Technology Fluxome, a Copenhagen-based Danish company, is a recognized leader in the field of industrial biotechnology. Fluxome uses its proprietary, cutting-edge microbial metabolic engineering technology platform to build highly efficient cell factories for the production of a broad range of commercially important nutraceutical ingredients. Fluxome's technology allows the company to rapidly develop and commercialize high purity, natural products manufactured using cost-effective bioprocesses. | Health Technology |
Biocleave Ltd.
Biocleave Ltd. BiotechnologyHealth Technology Biocleave Ltd. develops and sells microbial technology for the production of renewable chemicals and biofuels. It also provides biobutanol and other C4 chemical products. The firm also engages in microbiology and metabolic engineering through fermentation and commercial production scale. Its products include biobutanol chemicals and fuel, acetone, and butyric acid. The company was founded by Edward M. Green in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Alaska Food Diagnostics Ltd.
Alaska Food Diagnostics Ltd. Miscellaneous Commercial ServicesCommercial Services Alaska Food Diagnostics Ltd. provides ultrasensitive rapid detection systems to the food and beverage markets. It offers FastrAK Salmonella, an ultra rapid testing system for food manufacturers. The company was founded in August 2000 and is headquartered in Salisbury, UK. | Commercial Services |
AK Diagnostics Europe BV
AK Diagnostics Europe BV Miscellaneous Commercial ServicesCommercial Services Formed in 2008 as joint venture Company between Dutch Technology Fund I.B.V. and Alaska Food Diagnostics Ltd (UK), AK Diagnostics is further developing and marketing Alaska's AK-PhageTM Technology to provide new benefits in pathogen screening in the Primary Food Sector. Together with Alaska and RnA Assays BV, AK Diagnostics is collaborating in a EUREKA approved project for the testing of blood, meat drip and eggs of animals (principally pigs, cattle and poultry) at farm level or during slaughter. | Commercial Services |
FRX Polymers, Inc.
FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | Process Industries |
FlandersBio vzw
FlandersBio vzw Miscellaneous Commercial ServicesCommercial Services FlandersBio vzw is a life sciences cluster organization based in Flanders, Belgium. FlandersBio creates value by organizing networking and training activities, supporting internationalization, providing services, and building expertise. The Belgian company was founded by Jean Marie Stassen. | Commercial Services |
Frx Polymers NV
Frx Polymers NV Chemicals: SpecialtyProcess Industries Frx Polymers NV is a Belgian company that manufactures and supplies homopolymers, copolymers, and oligomers. The private company is based in Antwerp, Belgium. | Process Industries |
- Stock Market
- Insiders
- Claude J. Stoufs